Impact Biomedical (IBO) Other Operating Expenses (2022 - 2026)
Impact Biomedical (IBO) posted Other Operating Expenses of $675000.0 for Q1 2026, down 3.98% on a QoQ basis from $703000.0 in Q3 2025, and down 9.15% year-over-year from $743000.0 in Q1 2025.
Impact Biomedical (IBO) Other Operating Expenses (2022 - 2026) Analysis & Trends
Impact Biomedical's Other Operating Expenses history runs 5 years deep, the most recent figure standing at $675000.0 for Q1 2026.
- Quarterly Other Operating Expenses fell 9.15% year-over-year to $675000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 91.89% YoY) and the FY2024 annual result came in at $28.1 million, up 711.72% from the prior year.
- Other Operating Expenses was $675000.0 for Q1 2026 at Impact Biomedical, down from $703000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $26.5 million in Q4 2024 and bottomed at $440000.0 in Q1 2024.
- A 5-year average of $2.4 million and a median of $675000.0 in 2026 frame the typical range for Other Operating Expenses.
- Peak annual rise in Other Operating Expenses reached 1314.46% in 2024, while the deepest fall reached 50.9% in 2024.
- Impact Biomedical's Other Operating Expenses stood at $443000.0 in 2022, then soared by 323.02% to $1.9 million in 2023, then soared by 1314.46% to $26.5 million in 2024, then tumbled by 97.35% to $703000.0 in 2025, then decreased by 3.98% to $675000.0 in 2026.
- Business Quant data shows IBO's Other Operating Expenses at $675000.0 in Q1 2026, $703000.0 in Q3 2025, and $913000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 675,000.00 |
| Sep 30, 2025 | 703,000.00 |
| Jun 30, 2025 | 913,000.00 |
| Mar 31, 2025 | 743,000.00 |
| Dec 31, 2024 | 26.51 Mn |
| Sep 30, 2024 | 534,000.00 |
| Jun 30, 2024 | 463,000.00 |
| Mar 31, 2024 | 440,000.00 |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 937,000.00 |
| Jun 30, 2023 | 943,000.00 |
| Mar 31, 2023 | 505,000.00 |
| Dec 31, 2022 | 443,000.00 |
| Sep 30, 2022 | 462,000.00 |
| Jun 30, 2022 | 507,000.00 |